TECHLAB® Diagnostic Solutions | AnalytiChem Life Sciences

AnalytiChem partners with TECHLAB®, part of the SSI Diagnostica Group and a leading manufacturer of in vitro diagnostic assays for enteric pathogens, intestinal inflammation, and infectious diseases. Through our partnership, laboratories across the Benelux region gain access to trusted diagnostic solutions supported by local technical expertise and customer service.

Applications

Clinical Diagnostics
Enteric Pathogen Detection
C. difficile Testing
ELISA Diagnostics
Rapid Testing

Availability

Available through AnalytiChem in:
Netherlands | Belgium | Luxembourg

C. difficile Fecal Leukocyte Foodborne Pathogens Parasites Intestinal Inflammation

C. difficile Diagnostics

CDIFF_Quik-Chek_COMPLETE-768x512

TECHLAB produces a panel of in vitro diagnostics for detecting C. difficile and its toxins in fecal specimens from patients suspected of having the disease.

Their rapid and classical ELISA-based assays facilitates the detection of Clostridioides difficile toxins and GDH antigen.

Featured products:

C. DIFF QUIK CHEK® COMPLETE
C. DIFF QUIK CHEK®
TOX A/B QUIK CHEK®
C. DIFF CHEK™ - 60
C. DIFFICILE TOX A/B II™
C. difficile Toxin/Antitoxin Kit
C. DIFFICILE TOX-B TEST

Fecal Leukocyte Screening

LEUKO EZ VUE

Products supporting rapid intestinal inflammation and gastrointestinal screening workflows.

Foodborne Pathogens

TL_CAMPY_CHEK-0020_completed

TECHLAB manufactures diagnostics for two common foodborne pathogens, Shiga toxin-producing Escherichia coli (STEC) and Campylobacter species.

Their assays are for the detection of foodborne pathogens, to support routine clinical diagnostics.

Parasitology Diagnostics

TL_PARA_TRICOMBO_9638_completed

TECHLAB manufactures diagnostics for common intestinal parasites.

They provide diagnostics for Giardia, Cryptosporidium and Entamoeba histolytica.

Intestinal Inflammation Testing

LACTOFERRIN-EZ-VUE-Cassette-Reagents-Red-text

TECHLAB manufactures several diagnostics that detect lactoferrin
and other markers of inflammation

They provide diagnostic assays designed to support intestinal inflammation screening and gastrointestinal disease investigation.

Featured products:

LACTOFERRIN SCAN®

LACTOFERRIN CHEK®

LACTOFERRIN EZ VUE®

ASCA-CHEK™

About TECHLAB

Founded in 1989 and headquartered in Blacksburg, Virginia, TECHLAB develops and manufactures innovative in vitro diagnostic assays for infectious and intestinal diseases. The company is internationally recognised for its expertise in enteric pathogen diagnostics, particularly Clostridioides difficile testing.

Since 2022, TECHLAB has been part of the SSI Diagnostica Group, strengthening its position within the global infectious disease diagnostics market.

TECHLAB products are manufactured under ISO 13485 and MDSAP certified quality systems and are commercially available worldwide.

ISO 13485 Certified
MDSAP Certified
FDA Registered
Part of SSI Diagnostica Group

TECHLAB and AnalytiChem

AnalytiChem works in partnership with TECHLAB to provide laboratories in the Benelux region with access to specialised clinical and microbiology diagnostic solutions.

Through our established commercial and technical network, we support customers with:

Product guidance and technical support
Local sales and customer service
Access to specialist diagnostic solutions
Regional distribution and supply support

This partnership strengthens AnalytiChem’s clinical diagnostics offering while enabling laboratories to access proven testing technologies from a globally recognised diagnostic manufacturer.

Why Laboratories Choose TECHLAB

Proven Expertise in C. difficile Diagnostics
TECHLAB is widely recognised for its strong clinical focus and expertise in Clostridioides difficile testing.

Integrated Diagnostic Workflow
C. DIFF QUIK CHEK® COMPLETE combines GDH antigen and toxins A & B detection within a single test format.

Rapid Turnaround Times
Many assays deliver results within 10–30 minutes, supporting efficient laboratory workflows.

Clinically Validated Performance
TECHLAB products are supported by peer-reviewed studies and long-standing clinical adoption.

Continuous Innovation
Ongoing in-house research and development supports continued advancement in infectious disease diagnostics.